ClinicalTrials.gg
Not yet recruitingNCT07836153Updated Sep 23, 2026

Mechanical Power and Mortality in Mechanically Ventilated Adults

An observational study in Mechanical Ventilation Complication, Ventilator Induced Lung Injury and ARDS, sponsored by Zagazig University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by Zagazig University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
116
Ages
18 Years and older
Sex
All
01

Study summary

This prospective observational cohort study aims to investigate the relationship between mechanical power during the first 72 hours of invasive mechanical ventilation and 28-day mortality in mechanically ventilated adult patients admitted to the Surgical Intensive Care Unit at Zagazig University Hospitals.

Read the detailed description

This prospective observational cohort study will enroll adult patients admitted to the Surgical Intensive Care Unit who require invasive mechanical ventilation. Mechanical power will be calculated during the first 72 hours of invasive mechanical ventilation using ventilatory parameters recorded during routine clinical care. Patient demographic and clinical characteristics, respiratory and ventilatory parameters, and relevant laboratory data will be recorded. Patients will be followed during their ICU stay, and 28-day mortality will be assessed as the primary outcome. The association between mechanical power and 28-day mortality will be evaluated using appropriate statistical analyses, including receiver operating characteristic (ROC) curve analysis to assess the predictive performance of mechanical power.

02

Conditions studied

  • Mechanical Ventilation Complication
  • Ventilator Induced Lung Injury
  • ARDS
  • ICU Mortality (Survival Rate)

Keywords

  • Mechanical ventilation
  • Driving Pressure
  • 28-Day Mortality
  • Critically Ill Patients
03

In context

Ventilator-Induced Lung Injury

120 studies on the registry are indexed under Ventilator-Induced Lung Injury; 39 are open to participants now.

This study's planned enrollment of 116 is above the median of 60 across 42 observational studies indexed under Ventilator-Induced Lung Injury.

Browse Ventilator-Induced Lung Injury studies →

Lead sponsor

Zagazig University is the lead sponsor of 459 studies on the registry; 77 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients requiring invasive mechanical ventilation and admitted to the Surgical Intensive Care Unit at Zagazig University Hospitals.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥18 years.
  • Both sexes.
  • Patients requiring invasive controlled mechanical ventilation in the ICU and expected to require mechanical ventilation for at least 72 hours.
  • Enrollment within the first 8 hours after initiation of invasive mechanical ventilation.
  • Acceptance and written from a first-degree relative.

Exclusion criteria

Exclusion Criteria:

  • Predominant spontaneous breathing or weaning modes during the first 48 hours.
  • Severe hemodynamic instability precluding standardized measurements.
  • Prolonged mechanical ventilation prior to ICU admission.
  • Pregnancy.
  • Chest trauma.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
116 participants (estimated)
Patient registry
No

Groups and cohorts

  • Mechanically Ventilated Adult Patients

    Adult patients requiring invasive mechanical ventilation and admitted to the Surgical Intensive Care Unit at Zagazig University Hospitals.

06

What researchers measure

Primary outcomes

  1. 28-Day Mortality

    All-cause mortality within 28 days after initiation of invasive mechanical ventilation.

    Time frame: At 28 days after initiation of invasive mechanical ventilation

Secondary outcomes

  1. Driving Pressure and Plateau Pressure

    Correlation between mechanical power and driving pressure and plateau pressure at 24, 48, and 72 hours.

    Time frame: At 24, 48, and 72 hours after initiation of invasive mechanical ventilation

  2. Ventilator-Free Days

    Number of ventilator-free days within the first 28 days.

    Time frame: Through 28 days after initiation of invasive mechanical ventilation

  3. ICU Length of Stay

    Duration of stay in the intensive care unit

    Time frame: From ICU admission until ICU discharge or death, through 28 days after initiation of invasive mechanical ventilation

07

Study locations

1 site
  • Surgical Intensive Care Unit, Zagazig University Hospitals
    Zagazig, Sharqia Province, Egypt
    • Zagazig University · Contact
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07836153
Lead sponsor
Zagazig University
Responsible party
Sponsor
First posted
Sep 23, 2026
Start date
Sep 10, 2026 (estimated)
Primary completion
May 25, 2027 (estimated)
Completion
Aug 18, 2027 (estimated)
Last update
Sep 23, 2026

Study contacts

Tasneem Y Elshawadfy
Contact
Tasneemelserafy206@gmail.com
201097684895
Ghada M Abd Elrazik, Prof of anesthesia and Icu
study chair · Zagazig University
Asmaa M Galal Eldin, Assistant prof anesthesia,Icu
study chair · Zagazig University
Ahmed A Ibrahim, Lecturer of anesthesia, Icu
study chair · Zagazig University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion